Answers are grounded in this paper and cite their sources.
Beyond their substantial protection of individual vaccinees, it is hoped that the COVID-19 vaccines would reduce viral load in breakthrough infections thereby further suppress onward transmission. Here, analyzing positive SARS-CoV-2 test results following inoculation with the BNT162b2 mRNA vaccine, we find that the viral load is reduced 4-fold for infections occurring 12-28 days after the first dose of vaccine. These reduced viral loads hint to lower infectiousness, further contributing to vaccine impact on virus spread.
No takes yet. Share an insight, caveat, or question.
Levine-Tiefenbrun et al. (2021) studied this question.
Synapse has enriched 6 closely related papers on similar clinical questions. Consider them for comparative context: